- In the third quarter, New China Life reported a net income of 18.06 billion yuan.
- Earnings per share (EPS) for the third quarter were recorded at 5.79 yuan.
- For the first nine months, the company’s net income amounted to 32.86 billion yuan.
- The EPS over the nine-month period was 10.53 yuan.
- Analyst recommendations for New China Life include 10 buys, 3 holds, and 6 sells.
New China Life Insurance on Smartkarma
Analyst Coverage of New China Life Insurance on Smartkarma
On Smartkarma, the independent investment research network, top analysts have provided insightful coverage of New China Life Insurance. One notable report titled “Primer: New China Life Insurance (601336 CH) – Sep 2025″ by Ξ±SK highlights the company’s strategic shift towards profitability over scale. New China Life Insurance is focusing on high-margin products and long-term business value, showcasing strong double-digit growth in net income, EPS, and dividends despite negative revenue growth in recent years. This transformation, combined with the adoption of IFRS 17, aims to drive sustainable profitability for the company.
Moreover, the report emphasizes the favorable long-term industry tailwinds that support New China Life Insurance‘s growth. The Chinese life insurance market benefits from demographic and economic drivers such as an aging population, a growing middle class’s increasing awareness of health and retirement planning, and government backing for private pension systems. However, heightened investment risk amid market volatility is a key concern highlighted by the analysts. The company’s increased allocation to equities and equity-related funds, while seeking higher returns, also elevates its risk profile and makes earnings more vulnerable to capital market fluctuations, urging investors to closely monitor this aspect.
A look at New China Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysing the Smartkarma Smart Scores for New China Life Insurance reveals a positive long-term outlook for the company. With a strong focus on dividends and growth, scoring 5 in both categories, the company is expected to deliver solid returns to investors over time. Additionally, its momentum score of 4 suggests a promising upward trajectory in the market.
New China Life Insurance shows resilience with a score of 3, indicating its ability to withstand challenges and market fluctuations. While its value score is also respectable at 3, reflecting a good balance between price and intrinsic worth. Overall, the company’s strategic positioning and product offerings in life, accident, and health insurance bode well for its future performance and investor confidence.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
